A cross-sectional study to assess proteinuria and lipoprotein (a) levels in chronic kidney disease


Subalakshmi Radhakrishnan, Vijayapriya Indirajith, Periyandi Chandran, Ganesan Subramanyam, Menaha Ramu, Suganya Kandhi, Pothanur Mayavan Sasikala

Chronic kidney disease (CKD) is a reduced glomerular filtration rate and/or increased urinary albumin excretion. The worldwide prevalence of chronic kidney disease (CKD) ranges from 8 to 16 %, and the prevalence of CKD is rising.

The aim: To study the association between CKD stages, proteinuria, and lipoprotein (a) levels among the study participants.

Materials and methods: This study was an institution-based observational case-control study involving CKD patients as study group and healthy volunteers as control one. Blood samples were tested for urea, serum creatinine, uric acid levels, triglycerides, total cholesterol, HDL cholesterol, VLDL cholesterol and serum lipoprotein. Statistical analysis was done with SPSS version 20.0.

Result: In our study, the most common age group affected among cases was 41 to 50 years (5th decade), and there was a male preponderance in CKD. CKD patients had a higher mean protein creatinine ratio than controls, and this difference was statistically significant. In addition, CKD patients had significantly higher total cholesterol, triglyceride levels and lower HDL cholesterol levels than controls. Also, they had significantly elevated serum lipoprotein (a) levels than controls.

Conclusion: Based on our study findings, we can conclude that because of the potential role of lipoprotein (a) in the development of cardiovascular disease, it is imperative to include an estimation of lipoprotein (a) levels in all CKD patients, especially in later stages to give a targeted therapy for dyslipidemia among CKD patients

FULL PAPER

How to cite paper:

Radhakrishnan, S, , Indirajith, V, , Chandran, P, , Subramanyam, G, , Ramu, M, , Kandhi, S, , Sasikala, P, (2022). A cross-sectional study to assess proteinuria and lipoprotein (a) levels in chronic kidney disease. EUREKA: Health Sciences, 4, 32-38. doi:https://doi.org/10.21303/2504-5679.2022.002567